Dr Ed Barnes from the University of North Carolina at Chapel Hill talks with host Dr Raymond Cross from the University of Maryland about the new guidelines from the AGA on treating pouchitis.
Dr Millie Long and her IBD Drive Time cohost, Dr Raymond Cross, talk about ways health insurers create barriers to timely treatment for inflammatory bowel disease, particularly through requirements for prior authorization.
The results of the ATLANTIS trial showed that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms of irritable bowel syndrome as those taking a placebo. Co-chief investigator Alexander Ford, MD
In this podcast, Dr Lea Ann Chen explains how race/ ethnicity (White, Black, Hispanic, Asian) and immigration status (US-born vs foreign-born) influence IBD manifestations, disease onset, treatments, and outcomes.
In this episode of IBD Drive Time, guest Dr Adjoa Anyane-Yeboa of Massachusetts General Hospital talks with guest host Dr David Rubin of the University of Chicago about how social determinants of health can affect diagnosis and treatment of inf